Ana Facal

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

C. Solano, M. Sanz, J. Sanz, 2022, Bone Marrow Transplantation.

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

M. Terol, E. Soria-Olivas, C. Solano, 2022, Annals of Hematology.

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

C. Solano, M. Sanz, J. Sanz, 2022, Bone Marrow Transplantation.

T-cell Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.

M. Pasquini, M. Sanz, J. Sanz, 2023, Transplantation and cellular therapy.

IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

M. Sanz, J. Sanz, J. de la Rubia, 2023, Transplantation and cellular therapy.

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

C. Solano, D. Navarro, R. Martino, 2023, Blood Cancer Journal.

Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution

J. Sanz, J. de la Rubia, I. Gómez-Seguí, 2023, Journal of clinical medicine.